About Sanity Group
Sanity Group is a company based in Berlin (Germany) founded in 2011 was acquired by Organigram in February 2026. Sanity Group has raised $108.79 million across 6 funding rounds from investors including Organigram, British American Tobacco and Calyx. Sanity Group offers products and services including vaay, Vayamed, avaay Medical, Belfry Medical, and Endosane Pharmaceuticals. Sanity Group operates in a competitive market with competitors including ZYUS Life Sciences, Terraflos, Tetra Bio-Pharma, Avicanna and Aleafia Health, among others.
- Headquarter Berlin, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sanity Group Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$108.79 M (USD)
in 6 rounds
-
Latest Funding Round
$37.6 M (USD), Series B
Sep 27, 2022
-
Investors
Organigram
& 20 more
-
Employee Count
Not available
-
Acquired by
Organigram
(Feb 18, 2026)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sanity Group
Sanity Group offers a comprehensive portfolio of products and services, including vaay, Vayamed, avaay Medical, Belfry Medical, and Endosane Pharmaceuticals.
Platform for cannabis-related health services and distribution.
Service for medical cannabis products and advisory support.
Tool for medical cannabinoid applications and expertise sharing.
Provider of cannabinoid health solutions and partnerships.
Focuses on cannabinoid-based pharmaceutical developments.
People of Sanity Group
Unlock access to complete
Unlock access to complete
Funding Insights of Sanity Group
Sanity Group has successfully raised a total of $108.79M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $37.6 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sanity Group
Sanity Group has secured backing from 21 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include Organigram, British American Tobacco and Calyx.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are directed toward ICT and health tech startups.
|
Locked | Locked | Locked | |
|
Investment in cannabis industry startups is facilitated by Casa Verde.
|
Locked | Locked | Locked | |
|
Venture capital funding is provided to digital company founders.
|
Locked | Locked | Locked |
Investor details for Sanity Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sanity Group
Investment portfolio details for Sanity Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sanity Group
Detailed financials for Sanity Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sanity Group Comparisons
Peer comparison for Sanity Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sanity Group
Sanity Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ZYUS Life Sciences, Terraflos, Tetra Bio-Pharma, Avicanna and Aleafia Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cannabis-derived therapeutics for multiple indications are developed.
|
|
| Locked | Locked | Locked |
Medical cannabis products are provided based on GMP processes.
|
|
| Locked | Locked | Locked |
Natural medicinal plant-based elements are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Plant-derived cannabinoid products are developed for medical and consumer uses.
|
|
| Locked | Locked | Locked |
Cultivator and producer of cannabis plant for consumer wellness and research applications
|
Detailed competitors of Sanity Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sanity Group
Complete news archive for Sanity Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanity Group
Sanity Group was founded in 2011 and raised its 1st funding round 8 years after it was founded.
Sanity Group is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Sanity Group is a funded company, having raised a total of $108.79M across 6 funding rounds to date.
Developer of cannabinoid-based pharmaceuticals and well-being products The company develops pharmaceuticals and makes them accessible and available to pharmacists, physicians, and patients in Europe. It Also develops CBD and hemp-based products for wellbeing, relaxation, sleep aid, sports recovery gel. mouth spray for oral health and sanity Group is a developer of cannabinoid-based pharmaceuticals and well-being products.. hygiene, and CBD-based vaping pens.
Sanity Group's top competitors include Avicanna, ZYUS Life Sciences and Little Green Pharma.
Sanity Group offers vaay, Vayamed, avaay Medical, Belfry Medical, and Endosane Pharmaceuticals.
Sanity Group has 21 investors. Key investors include Organigram, British American Tobacco, Calyx, Alyssa Milano, and will.i.am.